IVISbrite™ Coelenterazine H in RediJect™ solution is a bioluminescent substrate in a ready-to-use injectable format developed by the in vivo imaging leaders to fit your laboratory workflow.
For research use only. Not for use in diagnostic procedures.
false false
With 爱游戏平台注册登录 ’s IVISbrite Coelenterazine h Bioluminescent Substrate in RediJect Solution, you can ensure reproducible results by minimizing variability in formulation, minimizing freeze/thaw and controlling batch to batch variation. IVISbrite Coelenterazine h bioluminescent substrate has been pre-formulated to fit common workflow patterns and optimize results for all your experiments with Renilla luciferase. The ready to use substrate formulation allows you to concentrate on animal handling and biology.
| 產品品牌名稱 | IVISbrite |
|---|---|
| 包裝量 | 10.0 Units |
| 運輸條件 | 藍冰 |
| Type | Coelenterazine |
| 產品尺寸 | 1 Kit (10 Vials) |
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
RediJect Coelenterazine h is a bioluminescence substrate in a ready-to-use format developed by the in vivo imaging leaders to fit your laboratory workflow. With 爱游戏平台注册登录 ’s RediJect Coelenterazine you can ensure reproducible results by minimizing variability in formulation, minimizing freeze/thaw ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
